کوینجێسترۆن

کوینجێسترۆن ھەروەھا بە (progesterone 3-cyclopentyl enol ether (PCPE)ـش ناسراوة، لەژێر ناوی بازرگانی (ئینۆل لوتیۆڤیس Enol-Luteovis) دا دەفرۆشرێت، دەرمانێکی پرۆجستینە کە پێشوو تر بۆ کۆنتڕۆلی دووگیانی بەکاردەھات لە ئیتاڵیا بەڵام چیتر ناخرێتە مارکێتەکانەوە^[١]^[٢]^[٣]^[٤]^[٥] لە ڕێگەی دەمەوە بەکاردێت^[٦]

سەرچاوەکان

↑ J. Elks (١٤ی تشرینی دووەمی ٢٠١٤). Elks، J؛ Ganellin، C. R (eds.). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. لاپەڕە ١٠٥٨. doi:١٠.١٠٠٧/٩٧٨-١-٤٧٥٧-٢٠٨٥-٣. ژپنک ٩٧٨-١-٤٧٥٧-٢٠٨٥-٣. OCLC ٨٩٨٥٦٤١٢٤.
↑ International Planned Parenthood Federation. Medical Committee. Oral Advisory Group (١٩٦٥). Handbook on oral contraception. Little, Brown. لاپەڕە ١٨. OCLC ٢٧١٧٥٩٣.
↑ Larrey D، Geneve J، Pessayre D، Machayekhi JP، Degott C، Benhamou JP (١٩٨٧). «Prolonged cholestasis after cyproheptadine-induced acute hepatitis». J. Clin. Gastroenterol. ٩ (1): ١٠٢–٤. doi:١٠.١٠٩٧/٠٠٠٠٤٨٣٦-١٩٨٧٠٢٠٠٠-٠٠٠٢٦. ISSN ٠١٩٢-٠٧٩٠. PMID ٣٥٥٩١٠٠. She had been taking an oral contraceptive combining ethinylestradiol and quingestrone since 1980.
↑ Denis Frank Hawkins (١٩٧٤). Obstetric therapeutics: clinical pharmacology and therapeutics in obstetric practice. Baillière Tindall. لاپەڕە ١٢٩, ١٣٨, ١٤٥. ژپنک ٩٧٨-٠-٧٠٢٠-٠٤٧١-١.
↑ P. J. Bentley (١٩٨٠). Endocrine Pharmacology: Physiological Basis and Therapeutic Applications. CUP Archive. لاپەڕە ٢٧٤–. ژپنک ٩٧٨-٠-٥٢١-٢٢٦٧٣-٨.
↑ Current Medicine and Drugs. ١٩٦٢. ISSN ٠٥٩٠-٤٠٤٨. Enol Luteovis (3 cyclo-pentyl enol ether of progesterone) is the only oral progestin producing pregnanediol as a metabolite. It is not very potent and probably carries very little risk of producing virilizing effects on a female foetus. Thus it is more closely related to progesterone than the other synthetic progestins.

دەروازەی زانست

[Elks2014-1] J. Elks (١٤ی تشرینی دووەمی ٢٠١٤). Elks، J؛ Ganellin، C. R (eds.). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. لاپەڕە ١٠٥٨. doi:١٠.١٠٠٧/٩٧٨-١-٤٧٥٧-٢٠٨٥-٣. ژپنک ٩٧٨-١-٤٧٥٧-٢٠٨٥-٣. OCLC ٨٩٨٥٦٤١٢٤.

[Group1965-2] International Planned Parenthood Federation. Medical Committee. Oral Advisory Group (١٩٦٥). Handbook on oral contraception. Little, Brown. لاپەڕە ١٨. OCLC ٢٧١٧٥٩٣.

[pmid_3559100-3] Larrey D، Geneve J، Pessayre D، Machayekhi JP، Degott C، Benhamou JP (١٩٨٧). «Prolonged cholestasis after cyproheptadine-induced acute hepatitis». J. Clin. Gastroenterol. ٩ (1): ١٠٢–٤. doi:١٠.١٠٩٧/٠٠٠٠٤٨٣٦-١٩٨٧٠٢٠٠٠-٠٠٠٢٦. ISSN ٠١٩٢-٠٧٩٠. PMID ٣٥٥٩١٠٠. She had been taking an oral contraceptive combining ethinylestradiol and quingestrone since 1980.

[Hawkins1974-4] Denis Frank Hawkins (١٩٧٤). Obstetric therapeutics: clinical pharmacology and therapeutics in obstetric practice. Baillière Tindall. لاپەڕە ١٢٩, ١٣٨, ١٤٥. ژپنک ٩٧٨-٠-٧٠٢٠-٠٤٧١-١.

[Bentley1980-5] P. J. Bentley (١٩٨٠). Endocrine Pharmacology: Physiological Basis and Therapeutic Applications. CUP Archive. لاپەڕە ٢٧٤–. ژپنک ٩٧٨-٠-٥٢١-٢٢٦٧٣-٨.

[CurrentMedicineAndDrugs1962-6] Current Medicine and Drugs. ١٩٦٢. ISSN ٠٥٩٠-٤٠٤٨. Enol Luteovis (3 cyclo-pentyl enol ether of progesterone) is the only oral progestin producing pregnanediol as a metabolite. It is not very potent and probably carries very little risk of producing virilizing effects on a female foetus. Thus it is more closely related to progesterone than the other synthetic progestins.

[١]

[٢]

[٣]

[٤]

[٥]

[٦]